Press Release & Publications

2023-11-09

鼓舞人心的AG-73305臨床 2a試驗數據顯示了初步安全性和有效性

DME患者中在單次玻璃體內注射0.5、1、2和4 mg劑量後，發現AG-7330 […]

2023-06-19

Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients

Taipei, Taiwan June. 19th, 2023 Allgenes […]

2023-05-29

Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema

Taipei, Taiwan May 24th, 2023 · AG-73305 […]

2023-04-18

Allgenesis Announces Last Patient Enrolled in the Phase 2a Trial Evaluating the Safety and Efficacy of AG-73305 in Diabetic Macular Edema (DME) Patients

Taipei, Taiwan/April 18, 2023 Allgenesis […]